By Kara Ngo A newly discovered gene therapy for Hemophilia B has demonstrated sustained safety and effectiveness over a 13-year period in June 2025. Conducted by researchers at St. Jude Children’s Research Hospital and University College London, this study is the longest follow-up reported for gene therapy targeting this